Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPID | Q08752 | 3/20 | 0.42 |
| ▸ | PPIB | P23284 | 1/20 | 0.42 |
| ▸ | PPIA | P62937 | 1/20 | 0.42 |
| ▸ | PPIG | Q13427 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30505642 | 1.00 | PPID (0.42) | PPIDPPIBPPIAPPIGHTT | |
| Hydrochloric Acid SCHEMBL5710126 | 0.99 | PPID (0.41) | PPIDPPIBPPIAPPIGHTT | |
| Hydrochloric Acid SCHEMBL27767646 | 0.99 | PPID (0.41) | PPIDPPIBPPIAPPIGHTT | |
| SCHEMBL11553376 | 0.90 | LTA4H (0.34) | PPIDPPIBPPIAPPIGALDH1A1 | |
| SCHEMBL11552559 | 0.87 | SMN1; SMN2 (0.37) | MAPTALDH1A1HPGDKMT2ATSHR | |
| SCHEMBL11548859 | 0.87 | ALDH1A1 (0.40) | ALDH1A1HPGDKMT2ALTA4HTSHR | |
| Hydrochloric Acid SCHEMBL5710314 | 0.86 | SMN1; SMN2 (0.36) | MAPTALDH1A1HPGDKMT2ATSHR | |
| SCHEMBL16063626 | 0.84 | HTT (0.48) | PPIDPPIBPPIAPPIGHTT | |
| SCHEMBL28208490 | 0.84 | PPID (0.39) | PPIDPPIBPPIAPPIGHTT | |
| SCHEMBL7162754 | 0.83 | ALDH1A1 (0.38) | ALDH1A1HPGDKMT2ATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116581427-B | Long-acting new energy battery thermal management liquid | 江苏艾德露环保科技有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-116581427-A | Long-acting new energy battery thermal management liquid | 江苏艾德露环保科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-108841363-B | Pure electric vehicle cooling liquid and preparation method and application thereof | 深圳市百顺源节能科技有限公司 | 2020-10-16 | — | — | CN | claimed |
| CN-108893180-A | A kind of Novel wide temperature domain lubricating oil and preparation method thereof | 张毅 | 2018-11-27 | — | — | CN | claimed |
| CN-103254197-A | Preparation method of anagrelide hydrochloride | UNIV HEILONGJIANG | 2013-08-21 | — | — | CN | claimed |
| US-6653500-B2 | Making ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine from 2,3-dichlorobenzaldehyde, reducing the glycine compound using tin dichloride or a catalyst and cyclization of the corresponding iminoquinazoline compound | SHIRE US INC. | 2003-11-25 | — | — | US | claimed |
| US-20030060630-A1 | Method for the manufacture of Anagrelide | SHIRE US INC. | 2003-03-27 | — | — | US | claimed |
| US-4208521-A | Process for the preparation of imidazo[2,1-b]quinazolinones | BRISTOL-MYERS COMPANY (US) | 1980-06-17 | — | — | US | claimed |
| EP-3994238-B1 | LUBRICATING COMPOSITIONS CONTAINING BASIC ASHLESS ADDITIVES | LUBRIZOL CORP (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-116581427-B | Long-acting new energy battery thermal management liquid | 江苏艾德露环保科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116581427-B | Long-acting new energy battery thermal management liquid | 江苏艾德露环保科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116581427-A | Long-acting new energy battery thermal management liquid | 江苏艾德露环保科技有限公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-116581427-A | Long-acting new energy battery thermal management liquid | 江苏艾德露环保科技有限公司 | 2023-08-11 | — | — | CN | disclosed |
| WO-2023144761-A1 | PROCESS FOR THE PREPARATION OF ANAGRELIDE HYDROCHLORIDE MONOHYDRATE | PIRAMAL PHARMA LIMITED (IN) | 2023-08-03 | — | — | WO | disclosed |
| EP-0778258-A2 | Process for the preparation of ethyl-n-(2,3 dichloro-6-nitrobenzyl) glycine | ROBERTS LABORATORIES INC. (US) | 1997-06-11 | — | — | EP | disclosed |
| EP-0514917-B1 | Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1996-12-27 | — | — | EP | disclosed |
| US-5391737-A | Process for the preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one | EGIS GYOGYSZERGYAR (HU) | 1995-02-21 | — | — | US | disclosed |
| EP-0514917-A1 | Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives | EGIS GYOGYSZERGYAR (HU) | 1992-11-25 | — | — | EP | disclosed |
| US-4208521-A | Process for the preparation of imidazo[2,1-b]quinazolinones | BRISTOL-MYERS COMPANY (US) | 1980-06-17 | — | — | US | disclosed |
| US-4146718-A | BLOOD PLATELET ANTIAGGREGATIVE AGENT | BRISTOL-MYERS COMPANY (US) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030060630-A1 | Method for the manufacture of Anagrelide | SUCLG2, PDCD2L, ICOSLG | PPID 344/4885PPIB 464/4885PPIA 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.